RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.

Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.

Updates are delayed or unverified. Check original sources for the latest information.

Your saved research and appointment questions

View recorded trial and retraction changes

ICD K83.0ORPHA:171PSC

Primary Sclerosing Cholangitis

Primary Sclerosing Cholangitis is a chronic progressive disease of the bile ducts characterised by inflammation and fibrosis, leading to strictures, liver failure, and a significantly elevated risk of cholangiocarcinoma. It is strongly associated with inflammatory bowel disease, particularly ulcerative colitis. No effective medical treatment exists; liver transplantation is the only definitive therapy for advanced disease.

This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.

632
Articles
92
Trials (4 AU)
Data refreshed
19 October 2026
Loading...

Common Questions

What is Primary Sclerosing Cholangitis?

Primary Sclerosing Cholangitis is a chronic progressive disease of the bile ducts characterised by inflammation and fibrosis, leading to strictures, liver failure, and a significantly elevated risk of cholangiocarcinoma. It is strongly associated with inflammatory bowel disease, particularly ulcerative colitis. No effective medical treatment exists; liver transplantation is the only definitive therapy for advanced disease.

How many clinical trials are available for Primary Sclerosing Cholangitis?

RareWays currently indexes 92 clinical trials for Primary Sclerosing Cholangitis, of which 15 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.

Where does the research data for Primary Sclerosing Cholangitis come from?

RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.

Get research updates

Monthly email when new findings are published for Primary Sclerosing Cholangitis.

Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.

This information is for general awareness only.

For guidance specific to your situation, please speak with your healthcare team.